Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-17

Clinical Trial Update: Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects [Phase 2]

View source ↗

Summary

This Phase 2 study reports long-term efficacy and safety of HRS-7535 tablets for chronic weight management in obese adults. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-7535 tablets (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Chronic Weight Management | Phase 2 | Status: COMPLETED